Pediatric humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and two-dose vaccination during SARS-CoV-2 omicron BA.5 and BN.1 variants predominance in South Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- FRONTIERS IN IMMUNOLOGY14 · 2023
- 피인용
- Web of Science 6Scopus 6
- FWCI (Scopus)
- 0.45
- JCR IF
- JCR 2022 7.3
- ISSN
- 1664-3224
저자
- Choi, Hyun-Woo제1저자Chonnam Natl Univ Hosp, Dept Lab Med, Gwangju, South Korea
- Achangwa, ChiaraKonyang Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea
- Park, JoonhongJeonbuk Natl Univ, Dept Lab Med, Med Sch & Hosp, Jeonju, South Korea
- 이선민Pusan Natl Univ, Sch Med, Dept Lab Med, Pusan, South Korea
- Lee, Nan YoungKyungpook Natl Univ, Sch Med, Dept Clin Pathol, Daegu, South Korea
- Jeon, Chae-HyeonChonnam Natl Univ, Med Sch, Res Inst Med Sci, BioMed Sci Grad Program BMSGP, Hwasun, South Korea
- Choi, Jeong-HwaChonnam Natl Univ, Med Sch, Res Inst Med Sci, BioMed Sci Grad Program BMSGP, Hwasun, South Korea
- Do, Hyun KyungKonyang Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea
- Nam, Jeong-HyunKorea Dis Control & Prevent Agcy, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res,Natl Inst Hlth, Cheongju, South Korea
- Lee, June-WooKorea Dis Control & Prevent Agcy, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res,Natl Inst Hlth, Cheongju, South Korea
- Kim, ByounggukKorea Dis Control & Prevent Agcy, Natl Inst Infect Dis, Ctr Vaccine Res, Div Vaccine Clin Res,Natl Inst Hlth, Cheongju, South Korea
- Ryu, Sukhyun교신저자Konyang Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea
- Kee, Seung-Jung교신저자Chonnam Natl Univ Hosp, Dept Lab Med, Gwangju, South Korea
초록
Background: Humoral immune responses and infection risk after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) vaccination during the Omicron BA.5 and BN.1 variants predominant period remains unexplored in pediatric population. Methods: We examined anti-spike (anti-S) immunoglobulin G (IgG) responses in a total of 986 children aged 4−18 years who visited outpatient clinics between June 2022 and January 2023, with a history of SARS-CoV-2 infection alone, completed two doses of COVID-19 vaccination alone, vaccine-breakthrough infection (i.e., infection after the single dose of vaccination), and no antigenic exposure. Furthermore, to determine SARS-CoV-2 infection risk, the incidence of newly developed SARS-CoV-2 infection was investigated up to March 2023. Results: The anti-S IgG levels in the ‘vaccine-breakthrough infection’ group exceeded those in the ‘infection alone’ and ‘vaccination alone’ groups (both P <0.01). Furthermore, the ‘vaccination alone’ group experienced more rapid anti-S IgG waning than the ‘infection alone’ and ‘vaccine-breakthrough infection’ groups (both P <0.01). We could not identify newly developed SARS-CoV-2 infection in the ‘vaccine-breakthrough infection’ group. Conclusion: Our findings suggest that hybrid immunity, acquired from SARS-CoV-2 infection and COVID-19 vaccination, was a potentially higher and longer-lasting humoral immune response and protected against SARS-CoV-2 infection in pediatric population during Omicron BA.5 and BN.1 variants predominant.
키워드
antibody responsechildCOVID-19hybrid immunitySARS-CoV-2vaccineANTIBODIESSEROPREVALENCE
식별자
- Scopus EID
- 2-s2.0-85181228404
- WoS UID
- 001134892300001



로그인
연구물 목록으로